Literature DB >> 9605317

The role of polar interactions in the molecular recognition of CD40L with its receptor CD40.

J Singh1, E Garber, H Van Vlijmen, M Karpusas, Y M Hsu, Z Zheng, J H Naismith, D Thomas.   

Abstract

CD40 Ligand (CD40L) is transiently expressed on the surface of T-cells and binds to CD40, which is expressed on the surface of B-cells. This binding event leads to the differentiation, proliferation, and isotype switching of the B-cells. The physiological importance of CD40L has been demonstrated by the fact that expression of defective CD40L protein causes an immunodeficiency state characterized by high IgM and low IgG serum levels, indicating faulty T-cell dependent B-cell activation. To understand the structural basis for CD40L/CD40 association, we have used a combination of molecular modeling, mutagenesis, and X-ray crystallography. The structure of the extracellular region of CD40L was determined by protein crystallography, while the CD40 receptor was built using homology modeling based upon a novel alignment of the TNF receptor superfamily, and using the X-ray structure of the TNF receptor as a template. The model shows that the interface of the complex is composed of charged residues, with CD40L presenting basic side chains (K143, R203, R207), and CD40 presenting acidic side chains (D84, E114, E117). These residues were studied experimentally through site-directed mutagenesis, and also theoretically using electrostatic calculations with the program Delphi. The mutagenesis data explored the role of the charged residues in both CD40L and CD40 by switching to Ala (K143A, R203A, R207A of CD40L, and E74A, D84A, E114A, E117A of CD40), charge reversal (K143E, R203E, R207E of CD40L, and D84R, E114R, E117R of CD40), mutation to a polar residue (K143N, R207N, R207Q of CD40L, and D84N, E117N of CD40), and for the basic side chains in CD40L, isosteric substitution to a hydrophobic side chain (R203M, R207M). All the charge-reversal mutants and the majority of the Met and Ala substitutions led to loss of binding, suggesting that charged interactions stabilize the complex. This was supported by the Delphi calculations which confirmed that the CD40/CD40L residue pairs E74-R203, D84-R207, and E117-R207 had a net stabilizing effect on the complex. However, the substitution of hydrophilic side chains at several of the positions was tolerated, which suggests that although charged interactions stabilize the complex, charge per se is not crucial at all positions. Finally, we compared the electrostatic surface of TNF/TNFR with CD40L/CD40 and have identified a set of polar interactions surrounded by a wall of hydrophobic residues that appear to be similar but inverted between the two complexes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605317      PMCID: PMC2144015          DOI: 10.1002/pro.5560070506

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  35 in total

1.  Analysis of gp39/CD40 interactions using molecular models and site-directed mutagenesis.

Authors:  J Bajorath; J S Marken; N J Chalupny; T L Spoon; A W Siadak; M Gordon; R J Noelle; D Hollenbaugh; A Aruffo
Journal:  Biochemistry       Date:  1995-08-08       Impact factor: 3.162

2.  Humoral immune responses in CD40 ligand-deficient mice.

Authors:  B R Renshaw; W C Fanslow; R J Armitage; K A Campbell; D Liggitt; B Wright; B L Davison; C R Maliszewski
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

3.  Cloning of TRAP, a ligand for CD40 on human T cells.

Authors:  D Graf; U Korthäuer; H W Mages; G Senger; R A Kroczek
Journal:  Eur J Immunol       Date:  1992-12       Impact factor: 5.532

4.  Molecular and biological characterization of a murine ligand for CD40.

Authors:  R J Armitage; W C Fanslow; L Strockbine; T A Sato; K N Clifford; B M Macduff; D M Anderson; S D Gimpel; T Davis-Smith; C R Maliszewski
Journal:  Nature       Date:  1992-05-07       Impact factor: 49.962

5.  Identification of residues on CD40 and its ligand which are critical for the receptor-ligand interaction.

Authors:  J Bajorath; N J Chalupny; J S Marken; A W Siadak; J Skonier; M Gordon; D Hollenbaugh; R J Noelle; H D Ochs; A Aruffo
Journal:  Biochemistry       Date:  1995-02-14       Impact factor: 3.162

6.  Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses.

Authors:  M Roy; A Aruffo; J Ledbetter; P Linsley; M Kehry; R Noelle
Journal:  Eur J Immunol       Date:  1995-02       Impact factor: 5.532

7.  Mice deficient for the CD40 ligand.

Authors:  J Xu; T M Foy; J D Laman; E A Elliott; J J Dunn; T J Waldschmidt; J Elsemore; R J Noelle; R A Flavell
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

8.  Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.

Authors:  C Mohan; Y Shi; J D Laman; S K Datta
Journal:  J Immunol       Date:  1995-02-01       Impact factor: 5.422

9.  Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion.

Authors:  M K Spriggs; R J Armitage; L Strockbine; K N Clifford; B M Macduff; T A Sato; C R Maliszewski; W C Fanslow
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

10.  Characterization of nine novel mutations in the CD40 ligand gene in patients with X-linked hyper IgM syndrome of various ancestry.

Authors:  P Macchi; A Villa; D Strina; M G Sacco; F Morali; D Brugnoni; S Giliani; E Mantuano; A Fasth; B Andersson
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

View more
  20 in total

1.  A polymorphic CD40 ligand (CD154) molecule mediates CD40-dependent signalling but interferes with the ability of soluble CD40 to functionally block CD154:CD40 interactions.

Authors:  B Barnhart; G S Ford; A Bhushan; C Song; L R Covey
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  Modulation of the CD40-CD40 ligand interaction using human anti-CD40 single-chain antibody fragments obtained from the n-CoDeR phage display library.

Authors:  Peter Ellmark; Camilla Ottosson; Carl A K Borrebaeck; Ann-Christin Malmborg Hager; Christina Furebring
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

3.  Expression and purification of soluble murine CD40L monomers and polymers in yeast Pichia pastoris.

Authors:  Christina E Hermanrud; Carrie L Lucas; Megan Sykes; Christene A Huang; Zhirui Wang
Journal:  Protein Expr Purif       Date:  2010-11-11       Impact factor: 1.650

4.  The interaction of neurotrophins with the p75NTR common neurotrophin receptor: a comprehensive molecular modeling study.

Authors:  I L Shamovsky; G M Ross; R J Riopelle; D F Weaver
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

5.  Crystallographic and mutational analysis of the CD40-CD154 complex and its implications for receptor activation.

Authors:  Hyun-Jung An; Young Jin Kim; Dong Hyun Song; Beom Suk Park; Ho Min Kim; Ju Dong Lee; Sang-Gi Paik; Jie-Oh Lee; Hayyoung Lee
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

Review 6.  Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions.

Authors:  Damir Bojadzic; Peter Buchwald
Journal:  Curr Top Med Chem       Date:  2018       Impact factor: 3.295

7.  A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss.

Authors:  Kazuhiro Aoki; Hiroaki Saito; Cecile Itzstein; Masaji Ishiguro; Tatsuya Shibata; Roland Blanque; Anower Hussain Mian; Mariko Takahashi; Yoshifumi Suzuki; Masako Yoshimatsu; Akira Yamaguchi; Pierre Deprez; Patrick Mollat; Ramachandran Murali; Keiichi Ohya; William C Horne; Roland Baron
Journal:  J Clin Invest       Date:  2006-05-04       Impact factor: 14.808

8.  Identifying the determinants in the equatorial domain of Buchnera GroEL implicated in binding Potato leafroll virus.

Authors:  S A Hogenhout; F van der Wilk; M Verbeek; R W Goldbach; J F van den Heuvel
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

9.  Analysis of Fas-ligand interactions using a molecular model of the receptor-ligand interface.

Authors:  J Bajorath
Journal:  J Comput Aided Mol Des       Date:  1999-07       Impact factor: 3.686

10.  An insecticidal GroEL protein with chitin binding activity from Xenorhabdus nematophila.

Authors:  Mohan Chandra Joshi; Animesh Sharma; Sashi Kant; Ajanta Birah; Gorakh Prasad Gupta; Sharik R Khan; Rakesh Bhatnagar; Nirupama Banerjee
Journal:  J Biol Chem       Date:  2008-07-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.